Technology
The FDA has approved Rasonque, a novel treatment for advanced pancreatic cancer, showing significant improvements in patient outcomes.
Technology
Pharmaceutical giants are poised to unveil data on new cardiovascular drugs targeting lipoprotein(a), marking a potential breakthrough in treatment.
Technology
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
Finance
Recent findings highlight the surprising surge in health care costs for major companies, prompting scrutiny and reevaluation of existing healthcare strategies.
Technology
A notable drop in GLP-1 drug coverage among U.S. employers coincides with a decline in Massachusetts' biotech workforce, highlighting industry challenges.
Finance
A new wave of drug trials aims to tackle genetic heart disease risk factors, particularly targeting Lp(a), with major implications for the pharmaceutical market.
Finance
Addressing women's health disparities could generate significant economic gains, with estimates suggesting a $1 trillion boost worldwide by 2040.
Technology
Recent analyses indicate that post-Dobbs predictions about abortion rates and health impacts may not align with current realities.
Technology
Roche's significant investment in the U.S. coincides with heightened demand for estrogen patches, now facing severe production challenges.
Technology
Recent observations suggest cancer patients might be receiving unwarranted high doses and lengthy treatments of costly medications.
Technology
With Ebola cases rising sharply in the DRC, Merck's vaccine is set for deployment to enhance response efforts, including a significant clinical trial.
Technology
Focal therapy is increasingly considered in prostate cancer treatment, offering a targeted approach with fewer side effects than traditional methods.
Technology
Lil Nas X's bipolar diagnosis highlights a troubling paradox where acknowledgment of distress often clashes with the pursuit of success and treatment fears.
Technology
Long-term HIV survivors worry that a cure might jeopardize their essential support services, highlighting the need for thoughtful policy considerations.
Technology
Regeneron and Ultragenyx receive FDA approvals for significant therapies aimed at rare diseases, offering new hope for affected patients.